Endogenous retroviruses: Suspects in the disease world

Future Microbiology

Volumn 2, Issue 3, 2007, Pages 269-275

  Singh, Sunit Kumar ^a  

^a CENTRE FOR CELLULAR AND MOLECULAR BIOLOGY   (India)

Author keywords

Autoimmunity; Diseases; Human endogenous retroviruses; Multiple sclerosis; Pathology; Physiology; Syncytin

Indexed keywords

CARCINOGEN; VIRUS DNA;

ARTICLE; ENDOGENOUS RETROVIRUS; GENE MUTATION; GERM LINE; HEREDITY; HUMAN; HUMAN GENOME; KERATINOCYTE; LYMPHOCYTE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; RESERVOIR; SALIVARY GLAND; VIRUS CELL INTERACTION; VIRUS GENE; VIRUS INFECTION; VIRUS MORPHOLOGY; VIRUS PARTICLE; VIRUS TRANSMISSION;

ENDOGENOUS RETROVIRUSES; GENES, VIRAL; GENOME, HUMAN; HUMANS; MODELS, GENETIC; VIRUS INTEGRATION;

HUMAN ENDOGENOUS RETROVIRUSES;

EID: 34547564656     PISSN: 17460913     EISSN: None     Source Type: Journal    
DOI: 10.2217/17460913.2.3.269     Document Type: Article

References (62)

1. Perron H, Jouvin-Marche E, Michel M et al.: Multiple sclerosis retrovirus particles and recombinant envelope trigger an abnormal immune response in vitro, by inducing polyclonal Vβ16 T-lymphocyte activation. Virology 287(2), 321-332 (2001).
2. Rolland A, Jouvin-Marche E, Saresella M et al.: Correlation between disease severity and in vitro cytokine production mediated by MSRV (multiple sclerosis associated retroviral element) envelope protein in patients with multiple sclerosis. J. Neuroimmunol. 160(1-2), 195-203 (2005).
3. Larsson E, Venables PJ, Andersson AC et al.: Expression of the endogenous retrovirus ERV3 (HERV-R) during induced monocytic disfferentiation in the U-937 cell line. Int. J. Cancer. 67(3), 451-456 (1996).
4. Hughes JF, Coffin JM: Evidence for genomic rearrangements mediated by human endogenous retroviruses during primate evolution. Nat. Genet. 29(4), 487-489 (2001).
5. Costas J: Characterization of the intragenomic spread of the human endogenous retrovirus family HERV-W. Mol. Biol. Evol. 19(4), 526-533 (2002).
6. Antony JM, van Marle G, Opii W et al.: Human endogenous retrovirus glycoprotein-mediated induction of redox reactants causes oligodendrocyte death and demyelination. Nat. Neurosci. 7(10), 1088-1095 (2004).
7. Ryan FP: Human endogenous retroviruses in health and disease: a symbiotic perspective. J. R. Soc. Med. 97(12), 560-565 (2004).
8. Miyauchi M, Maruyama K: Morphological and antigenic variations of human T cell leukemia virus type I particles in human lymphocytes. J. Electron. Microsc. (Tokyo) 39(3), 145-154 (1990).
9. Christensen T: Association of human endogenous retroviruses with multiple sclerosis and possible interactions with herpes viruses. Rev. Med. Virol. 15(3), 179-211 (2005).
10. Martin MA, Bryan T, Rasheed S, Khan AS: Identification and doning of endogenous retroviral sequences present in human DNA. Proc. Natl. Acad. Sci. USA 78(8), 4892-4896 (1981).
11. Bock M, Stoye JP: Endogenous retroviruses and the human germline. Curr. Opin. Genet. Dev. 10(6), 651-655 (2000).
12. Griffiths DJ: Endogenous retroviruses in the human genome sequence. Genome Biol. 2(6), (1017) (2001).
13. Lavillette D, Marin M, Ruggieri A, Mallet F, Cosset FL, Kabat D: The envelope glycoprotein of human endogenous retrovirus type W uses a divergent family of amino acid transporters/cell surface receptors. J. Virol. 76(13), 6442-6452 (2002).
14. Schon U, Seifarth W, Baust C, Hohenadl C, Erfle V, Leib-Mosch C: Cell type-specific expression and promoter activity of human endogenous retroviral long terminal repeats. Virology 279(1), 280-291 (2001).
15. Vinogradova TV, Leppik LP, Nikolaev LG et al.: Solitary human endogenous retroviruses-K LTRs retain transcriptional activity in vivo, the mode of which is different in different cell types. Virology 290(1), 83-90 (2001).
16. Andersson ML, Medstrand P, Yin H, Blomberg J: Differential oxpression of human endogenous retroviral sequences similar to mouse mammary tumor virus in normal peripheral blood mononuclear cells. AIDS Res. Hum Retroviruses. 12 (9), 833-840 (1996).
17. Taruscio D, Mantovani A: Factors regulating endogenous retroviral sequences in human and mouse. Cytogenet. Genome Res. 105(2-4), 351-362 (2004).
18. Gifford R, Tristem M: The evolution, distribution and diversity of endogenous retroviruses. Virus Genes 26 (3), 291-315 (2003).
19. Venables PJ, Brookes SM, Griffiths D, Weiss RA, Boyd MT. Abundance of an endogenous retroviral envelope protein in placental trophoblasts suggests a biological function. Virology 211(2), 589-592 (1995).
20. Turner G, Barbulescu M, Su M, Jensen-Seaman MI, Kidd KK, Lenz J: Insertional polymorphisms of full-length endogenous retroviruses in humans. Curr. Biol. 11 (19), 1531-1535 (2001).
21. Versteeg R, van Schalk BD, van Batenburg MF et al.: The human transcriptome map reveals extremes in gene density, intron length, GC content, and repeat pattern for domains of highly and weakly expressed genes. Genome Res. 13 (9), 1998-2004 (2003).
22. Abrink M, Larsson E, Hellman L: Demethylation of ERV3, an endogenous retrovirus regulating the Kruppel-related zinc finger gene H-plk, in several human cell lines arrested during early monocyte development. DNA Cell Biol. 17(1), 27-37 (1998).
23. Kjellman C, Sjogren HO, Salford LG, Widegren B: HERV-F (XA34) is a full-length human endogenous retrovirus expressed in placental and fetal tissues. Gene 239(1), 99-107 (1999).
24. Taruscio D, Floridia G, Zoraqi GK, Mantovard A, Falbo V: Organization and integration sites in the human genome of endogenous retroviral sequences belonging to HERV-E family. Mamm. Genome 13(4), 216-222 (2002).
25. Knerr I, Beinder E, Rascher W: Syncytin, a novel human endogenous retroviral gene in human placenta: evidence for its dysregulation in preeclampsia and HELLP syndrome. Am. J. Obstet. Gynecol. 186(2), 210-213 (2002).
26. Frendo JL, Olivier D, Cheynet V et al.: Direct involvement of HERV-W Env glycoprotein in human trophoblast cell fusion and differentiation. Mol. Cell. Biol. 23(10), 3566-3574 (2003).
27. de Parseval N, Lazar V, Casena JF, Benit L, Heidmann T: Survey of human genes of retroviral origin: identification and transcriptome of the genes with coding capacity for complete envelope proteins. J. Virol. 77(19), 10414-10422 (2003).
28. Garson J, Creange A, Dolei A et al. MSRV, Syncytin and the role of endogenous retroviral proteins in demyelination. Mult. Scler. 11 (2), 249-250 (2005).
29. Blond JL, Lavillette D. Cheynet V et al.: An envelope glycoprotein of the human endogenous retrovirus HERV-W is expressed in the human placenta and fuses cells expressing the type D mammalian retrovirus receptor. J. Virol. 74(7), 3321-3329 (2000).
30. Mi S, Lee X, Li X et al.: Syncytin is a captive retroviral envelope protein involved in human placental morphogenesis. Nature 403(6771), 785-789 (2000).
31. Katsumata K, Ikeda H, Sato M et al.: Cytokine regulation of env gene expression of human endogenous retrovirus-R in human vascular endothelial cells. Clin. Immunol. 93(1), 75-80 (1999).
32. Perl A: Role of endogenous retroviruses in autoimmune diseases. Rheum. Dis. Clin. North Am. 29(1), 123-143, vii (2003).
33. Ling J, Pi W, Bollag R et al.: The solitary long terminal repeats of ERV-9 endogenous retrovirus are conserved during primate evolution and possess enhancer activities in embryonic and hematopoietic cells. J. Virol. 76(5), 2410-2423 (2002).
34. Lasson E, Venables P, Andersson AC et al.: Tissue and differentiation specific expression on the endogenous retrovirus ERV3 (HERV-R) in normal human tissues and during induced monocytic differentiation in the U-937 cell line. Leukemia 11 (Suppl. 3), S142-S144 (1997).
35. Schneider PM, Witzel-Schlomp K, Rittner C, Zhang L: The endogenous retroviral insertion in the human complement C4 gene modulates the expression of homologous genes by antisense inhibition. Immunogenetics 53(1), 1-9 (2001).
36. Kelleher CA, Wilkinson DA, Freeman JD, Mager DL, Gelfand EW: Expression of novel-transposon-containing mRNAs in human T cells. J. Gen. Virol. 77 (Pt 5), 1101-1110 (1996).
37. Ono M, Kawakami M, Ushikubo H: Stimulation of expression of the human endogenous retrovirus genome by female steroid hormones in human breast cancer cell line T47D. J. Virol. 61(6), 2059-2062 (1987).
38. Vinogradova T, Leppik L, Kalinina E, Zhulidov P, Grzeschik KH, Sverdlov E: Selective differential display of RNAs containing interspersed repeats: analysis of changes in the transcription of HERV-K LTRs in germ cell tumors. Mol. Genet. Genomics. 266(5), 796-805 (2002).
39. Wang-Johanning F, Frost AR, Jian B et al.: Detecting the expression of human endogenous retrovirus E envelope transcripts in human prostate adenocarcinoma. Cancer 98 (1), 187-197 (2003).
40. Patzke S, Lindeskog M, Munthe E, Aasheim HC: Characterization of a novel human endogenous retrovirus, HERV-H/F, expressed in human leukemia cell lines. Virology 303(1), 164-173 (2002).
41. Depii S, Roche C, Dussart P, Prin L: Expression of a human endogenous retrovirus, HERV-K, in the blood cells of leukemia patients. Leukemia 16(2), 254-259 (2002).
42. Flori AR, Lower R. Schmitz-Drager BJ, Schulz WA: DNA methylation and expression of LINE-1 and HERV-K provirus sequences in urothelial and renal cell carcinomas. Br. J Cancer. 80(9), 1312-1321 (1999).
43. Nelson PN, Hooley P, Roden D et al.: Human endogenous retroviruses: transposable elements with potential? Clin. Exp. Immunol. 138 (1), 1-9 (2004).
44. Obermayer-Straub P, Manns MP: Hepatitis C and D, retroviruses and autoimmune manifestations. J Autaimmun. 16(3), 275-285 (2001).
45. Herve CA, Luglt EB, Brand A, Griffiths DJ, Venables PJ: Autoantibodies to human endogenous retrovirus-K are frequently detected in health and disease and react with multiple epitopes. Clin. Exp. Immunol. 128(1), 75-82 (2002).
46. Johnston JB, Silva C, Holden J. Warren KG, Clark AW, Power C: Monocyte activation and differentiation augment human endogenous retrovirus expression: Implications for inflammatory brain diseases. Ann. Neurol. 50(4), 434-442 (2001).
47. Serra C, Mameli G. Arru G, Sotgiu S. Rosatl G, Dolel A: In vitro modulation of the multiple sclerosis (MS)-associated retrovirus by cytokines: Implications for MS pathogenesis. J. Neurovirol. 9(6). 637-643 (2003).
48. Firouzi R, Rolland A, Michel M et al.: Multiple sclerosis-associated retrovirus particles cause T lymphocyte-dependent death with brain hemorrhage in humanized SCID mice model. J. Neurovirol. 9(1), 79-93 (2003).
49. Perron H, Garson JA, Bedin F et al.: Molecular identification of a novel retrovirus repeatedly isolated from patients with multiple sclerosis. The Collaborative Research Group on Multiple Sclerosis. Proc. Natl. Acad. Sci. USA 94(14), 7583-7588 (1997).
50. Perron H, Lalande B, Gratacap B et al.: Isolation of retrovirus from patients with multiple sclerosis. Lancet 337(8745), 862-863 (1991).
51. Perron H, Gratacap B, Lalande B et al.: In vitro transmission and antigenicity of a retrovirus isolated from a multiple sclerosis patient. Res. Virol. 143(5), 337-350 (1992).
52. Perron H, Firouzi R, Tuke P et al.: Cell cultures and associated retroviruses in multiple sclerosis. Collaborative Research Group on MS. Acta Neurol. Scand. Suppl. 169, 22-31 (1997).
53. Perron H, Geny C, Laurent A et al.: Leptomeningeal cell line from multiple sclerosis with reverse transcriptase activity and viral particles. Res. Virol. 140(6), 551-561 (1989).
54. Perron H, Suh M, Lalande B et al.: Herpes simplex virus ICP0 and ICP4 immediate early proteins strongly enhance expression of a retrovirus harboured by a leptomeningeal cell line from a patient with multiple sclerosis. J. Gen. Virol. 74(Pt 1), 65-72 (1993).
55. Christensen T, Jensen AW, Munch M et al.: Characterization of retroviruses from patients with multiple sclerosis. Acta Neurol. Scand. Suppl. 169, 49-58 (1997).
56. Komurian-Pradel F, Paranhos-Baccala G, Bedin F et al.: Molecular cloning and characterization of MSRV-related sequences associated with retrovirus-like particles. Virology 260(1), 1-9 (1999).
57. Garson JA, Tuke PW, Giraud P, Paranhos-Baccala G, Perron H: Detection of virion-associated MSRV-RNA in serum of patients with multiple sclerosis. Lancet 351(9095), 33 (1998).
58. Serra C, Sotgiu S, Mamell G, Pugliatti M, Rosati G, Dolei A: Multiple sclerosis and multiple sclerosis-associated retrovirus in Sardinia. Neurol. Sci. 22(2), 171-173 (2001).
59. Haahr S, Sommerlund M, Moller-Larsen A, Nielsen R, Hansen HJ: Just another dubious virus in cells from a patient with multiple sclerosis? Lancet 337(8745), 863-864 (1991).
60. Calabrese V, Scapagnini G, Ravagna A et al.: Nitric oxide synthase is present in the cerebrospinal fluid of patients with active multiple sclerosis and is associated with increases in cerebrospinal fluid protein nitrotyrosine and S-nitrosothiols and with changes in glutathione levels. J. Neurosci. Res. 70(4), 580-587 (2002).
61. Butterfield DA, Lauderback CM: Lipid peroxidation and protein oxidation in Alzheimer's disease brain: potential causes and consequences involving amyloid β-peptide-associated free radical oxidative stress. Free Radic. Biol. Med. 32(11), 1050-1060 (2002).
62. Hua LL, Kim MO, Brosnan CF, Lee SC: Modulation of astrocyte inducible nitric oxide synthase and cytokine expression by interferon β is associated with induction and inhibition of interferon γ-activated sequence binding activity. J. Neurochem. 83(5), 1120-1128 (2002).